WHO Collaborating Centres
Global database
Version 1.5
Search / List / Details
Ref.No. [Initiator]
MOR-13 [EMRO]
Status
Active
Title of the centre:
  WHO Collaborating Centre for Strengthening Pharmacovigilance Practices

Director / Head: 
  Pr Rachida Soulaymani Bencheikh
 




Institution:
  Centre Anti Poison et de Pharmacovigilance du Maroc
  Centre Anti Poison et de Pharmacovigilance du Maroc
Address:
  Rue Lamfadel Cherkaoui BP 66 71
  10 100
  Rabat
Town:
  Rabat
Country:
  MOROCCO
Region:
  EMRO
Phone:
  00 212 37 5 77 71 69
Fax:
  00 212 37 5 77 71 69
Web Site:
  http:// www.capm.ma
Date of Designation:
  02/Nov/2011
Last Redesignation:
  02/Nov/2015
Expiry:
  02/Nov/2019
Terms of Reference:
  1. To conduct and facilitate regional and national pharmacovigilance training courses, specifically for Francophone, Eastern Mediterranean and Arab countries 
  2. To support the WHO normative functions related to pharmacovigilance for medical products and promote patient safety 
  3. To assist WHO in the PV assessments and in the provision of technical support to Member States in strengthening pharmacovigilance systems for medical products in order to increase quality care to patients 
  4. To develop and manage a Vigilance platform in the EM Region for sharing information among French and Arab-speaking countries on safety of medical products between its Member States 
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  
Subjects:
  1. Pharmaceuticals (including essential drugs and medicines) 
  2. Patient safety 
  3. Health information; statistics; measurement & trend assessment 
Types of activity:
  1. Collection and collation of information 
  2. Research 
  3. Training and education 
WHO Outputs:
  Ower: 11.2 - International norms, standards and guidelines for the quality, safety, efficacy and cost effective use of medical products and technologies developed and their national and/or regional implementation advocated and supported.
  Ower: 10.1 - Management and organization of integrated, population-based health-service delivery through public and nonpublic providers and networks improved, reflecting the primary health care strategy, scaling up coverage, equity, quality and safety of personal and population-based health services, and enhancing health outcomes.
  Ower: 2.3 - Global guidance and technical support provided on policies and programmes in order to promote equitable access to essential medicines, diagnostic tools and health technologies of assured quality for the prevention and treatment of HIV/AIDS, tuberculosis and malaria, and their rational use by prescribers and consumers, and, in order to ensure uninterrupted supplies of diagnostics, safe blood and blood products, injections and other essential health technologies and commodities.
Responsible Officer:
  EVERARD Marthe M.
Phone:
  +202 227 65599
Email:
  everardm@who.int

Technical Counterpart:
  PAL Shanthi Narayan
Phone:
  +41 22 791 1318
Email:
  pals@who.int
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
  Link to eWork